TY - JOUR A1 - Bubna, Aditya T1 - Isotretinoin: In acne and beyond – An overview Y1 - 2020/7/1 JF - Indian Journal of Drugs in Dermatology JO - Indian J Drugs Dermatol SP - 59 EP - 69 VL - 6 IS - 2 UR - https://www.ijdd.in/article.asp?issn=2455-3972;year=2020;volume=6;issue=2;spage=59;epage=69;aulast=Bubna DO - 10.4103/ijdd.ijdd_11_19 N2 - Isotretinoin (ISO) has proven to be an extremely valuable drug for all dermatologists. Since its approval in 1982 by the US Food and Drug Administration for nodulocystic acne, it still remains the gold standard drug for the above indication till date, facing no competition from its contemporaries. Along with the treatment of nodulocystic acne, ISO has proved valuable in several other dermatoses as well. Further, even for treating acne, there have been a number of modifications as far as the prescription of ISO is concerned. This review will briefly highlight the various aspects of isotretinoin for acne and other cutaneous disorders. ER -